rt-cgm device dexcom g6 Search Results


dexcom g6 rt cgm  (Dexcom Inc)
86
Dexcom Inc dexcom g6 rt cgm
Dexcom G6 Rt Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/cgm+rt/10__1177_slash_15209156251412178-13307-10-10
Average 86 stars, based on 1 article reviews
dexcom g6 rt cgm - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
dexcom g6 rtcgm  (Dexcom Inc)
86
Dexcom Inc dexcom g6 rtcgm
Dexcom G6 Rtcgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/dexcom+g6+rtcgm+system/10__2337_slash_dc24___s007-150-0-0
Average 86 stars, based on 1 article reviews
dexcom g6 rtcgm - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
rtcgm  (Dexcom Inc)
86
Dexcom Inc rtcgm
Rtcgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/rtcgm/pm41709363-33-5-6
Average 86 stars, based on 1 article reviews
rtcgm - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
real time continuous glucose monitoring  (Dexcom Inc)
86
Dexcom Inc real time continuous glucose monitoring
Real Time Continuous Glucose Monitoring, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/cgm+real+time/pm39754348-0-11-16
Average 86 stars, based on 1 article reviews
real time continuous glucose monitoring - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
rtcgm devices  (Dexcom Inc)
86
Dexcom Inc rtcgm devices
Rtcgm Devices, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/dexcom+g6/10__2337_slash_dc24___s007-148-14-16
Average 86 stars, based on 1 article reviews
rtcgm devices - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
hcl system  (Dexcom Inc)
86
Dexcom Inc hcl system
Hcl System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/hcl+system/pmc12385850-68-4-15
Average 86 stars, based on 1 article reviews
hcl system - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
eversense e3  (Senseonics)
90
Senseonics eversense e3
Eversense E3, supplied by Senseonics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/eversense/pm36538774-39-12-11
Average 90 stars, based on 1 article reviews
eversense e3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
g7 rt cgm systems  (Dexcom Inc)
86
Dexcom Inc g7 rt cgm systems
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
G7 Rt Cgm Systems, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/cgm+systems/pmc13012535-117-11-6
Average 86 stars, based on 1 article reviews
g7 rt cgm systems - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
rt cgm data  (Dexcom Inc)
86
Dexcom Inc rt cgm data
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
Rt Cgm Data, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/cgm+data+dexcom+g6/10__1089_slash_dia__2022__2525__abstracts-4059-6-10
Average 86 stars, based on 1 article reviews
rt cgm data - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
interstitial sensor  (Dexcom Inc)
86
Dexcom Inc interstitial sensor
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
Interstitial Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/interstitial+sensor/pmc12454976-75-16-18
Average 86 stars, based on 1 article reviews
interstitial sensor - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
system  (Dexcom Inc)
86
Dexcom Inc system
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/one+system/pm41175314-196-15-14
Average 86 stars, based on 1 article reviews
system - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
dexcom g5  (Dexcom Inc)
86
Dexcom Inc dexcom g5
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
Dexcom G5, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+device+dexcom+g6/dexcom+g5/pm38476023-151-17-17
Average 86 stars, based on 1 article reviews
dexcom g5 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Net changes in non-insulin medication class count stratified by cohort and RT-CGM use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.

Journal: Diabetes, Metabolic Syndrome and Obesity

Article Title: Impact of Real-Time Continuous Glucose Monitoring on Medication Use and Glycemic Control in Type 2 Diabetes Across Therapy Regimens

doi: 10.2147/DMSO.S574769

Figure Lengend Snippet: Net changes in non-insulin medication class count stratified by cohort and RT-CGM use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.

Article Snippet: The RT-CGM group included individuals initiating Dexcom G4, G5, G6, or G7 RT-CGM systems, identified by National Drug Codes (NDCs; Supplementary Table 1 ), with the index date as the first RT-CGM claim.

Techniques: Medications

Proportion of each cohort achieving A1c targets stratified by RT-CGM use or CGM non-use. ( A ) Proportion of NIT cohort achieving A1c goals at follow-up, ( B ) Proportion of BIT cohort achieving A1c goals at follow-up, ( C ) Proportion of IIT cohort achieving A1c goals at follow-up, ( D and E ) Proportion of each cohort with a baseline A1c above the indicated target meeting the target at follow-up. **, p<0.001; ***, p<0.0001.

Journal: Diabetes, Metabolic Syndrome and Obesity

Article Title: Impact of Real-Time Continuous Glucose Monitoring on Medication Use and Glycemic Control in Type 2 Diabetes Across Therapy Regimens

doi: 10.2147/DMSO.S574769

Figure Lengend Snippet: Proportion of each cohort achieving A1c targets stratified by RT-CGM use or CGM non-use. ( A ) Proportion of NIT cohort achieving A1c goals at follow-up, ( B ) Proportion of BIT cohort achieving A1c goals at follow-up, ( C ) Proportion of IIT cohort achieving A1c goals at follow-up, ( D and E ) Proportion of each cohort with a baseline A1c above the indicated target meeting the target at follow-up. **, p<0.001; ***, p<0.0001.

Article Snippet: The RT-CGM group included individuals initiating Dexcom G4, G5, G6, or G7 RT-CGM systems, identified by National Drug Codes (NDCs; Supplementary Table 1 ), with the index date as the first RT-CGM claim.

Techniques: